Allergy Therapeutics looks forward to key hay fever trial

0
16

‘s () CFO Nick Wykeman and CEO Manuel Llobet join Proactive London’s Katie Pilbeam to discuss their record profits for the six-month stage, with revenues up 7% at GBP54mln for the half to December 31.

The group also posted pre-R&D operating income of GBP20.5mln, up 18.5%. The firm has highlighted top-line momentum and operational efficiency for the growth in profitability.

The operating margin advanced four percentage points to 38% year on year, while the cash balance was an impressive GBP48.3mln, or a net GBP44mln, up from GBP37mln 12 months earlier.

LEAVE A REPLY

Please enter your comment!
Please enter your name here